Letermovir Prophylaxis and Cytomegalovirus Reactivation in Adult Hematopoietic Cell Transplant Recipients with and without Acute Graft Versus Host Disease

Letermovir Prophylaxis and Cytomegalovirus Reactivation in Adult Hematopoietic Cell Transplant Recipients with and without Acute Graft Versus Host Disease

Cytomegalovirus (CMV) is the most clinically significant infection after allogeneic hematopoietic-cell transplantation (allo-HCT) and is associated with increased mortality. The risk for CMV reactivation increases with graft versus host disease (GVHD). GVHD contributes to significant morbidity and m...

Full description

Bibliographic Details
Main Authors: Delaney Wolfe, Qiuhong Zhao, Emma Siegel, Marcin Puto, Danielle Murphy, Julianna Roddy, Yvonne Efebera, Justin Tossey
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cancers
Subjects:
cytomegalovirus
graft versus host disease
allogeneic
letermovir
hematopoietic cell transplantation
Online Access:https://www.mdpi.com/2072-6694/13/21/5572

Similar Items

Similar Items